Showing 2,681 - 2,700 results of 16,418 for search '"Therapy"', query time: 0.09s Refine Results
  1. 2681

    Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases by James J. Cody, Pietro Scaturro, Alan B. Cantor, G. Yancey Gillespie, Jacqueline N. Parker, James M. Markert

    Published 2012-01-01
    “…Thus, we conclude from this proof-of-principle study that a γ134.5-deleted IL-12 expressing oncolytic HSV may be a potential new therapy for breast cancer brain metastases.…”
    Get full text
    Article
  2. 2682
  3. 2683

    Steroid Pulse Therapy for Severe Central Nervous System Involvement in Shiga Toxin-Producing Escherichia coli-Related Hemolytic Uremic Syndrome by Chiara Rosazza, Alberto M Cappellari, Cristiano Gandini, Elisa Scola, Gianluigi Ardissino

    Published 2021-01-01
    “…Therefore, neurologic manifestations were thought to be related to reperfusion damage to the CNS and high-dose IV steroid pulse therapy was empirically administered. Following this therapeutic scheme, neurologic involvement resolved with no sequelae. …”
    Get full text
    Article
  4. 2684
  5. 2685

    Components of cognitive–behavioural therapy for mitigating core symptoms in attention-deficit hyperactivity disorder: a systematic review and network meta-analysis by Sayo Hamatani, Kazuki Matsumoto, Yoshihiko Kunisato, Yoshifumi Mizuno

    Published 2024-12-01
    “…Question Cognitive–behavioural therapy (CBT) is frequently implemented for individuals with attention-deficit hyperactivity disorder (ADHD). …”
    Get full text
    Article
  6. 2686
  7. 2687
  8. 2688
  9. 2689
  10. 2690
  11. 2691

    Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis by Chun Shing Kwok, Heerajnarain Bulluck, Alisdair D. Ryding, Yoon K. Loke

    Published 2014-01-01
    “…The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is unclear. …”
    Get full text
    Article
  12. 2692

    Efek Electro Convulsive Therapy (ECT) terhadap Daya Ingat Pasien Skizofrenia di RSJ Prof. HB. Sa’anin Padang by Ikky Nabila Nandinanti, Yaslinda Yaunin, Siti Nurhajjah

    Published 2015-09-01
    “…<br />Kata kunci: skizofrenia, ECT, daya ingat</p><p> </p><p>Abstract <br />ECT is an electric convulsive therapy by delivering electrical current to electrodes and mounted on the head causing convulsions. …”
    Get full text
    Article
  13. 2693

    Resolution of Multiple Severe Nonsteroidal Anti-Inflammatory Drug-Induced Colonic Strictures with Prednisone Therapy: A Case Report and Review of the Literature by Robert M Penner, C Noel Williams

    Published 2003-01-01
    “…Discontinuation of NSAID therapy did not result in endoscopic change, but a 20-week course of prednisone was followed by complete resolution. …”
    Get full text
    Article
  14. 2694
  15. 2695
  16. 2696

    Spontaneous Bacterial Peritonitis Caused by Listeria monocytogenes Associated with Ascitic Fluid Lymphocytosis: A Case Report and Review of Current Empiric Therapy by Todd Yecies, Sanae Inagami

    Published 2013-01-01
    “…Given increasing rates of cefotaxime-resistant SBP alongside the possibility of Listeriosis, the use of cefotaxime as first-line therapy in SBP should be reevaluated.…”
    Get full text
    Article
  17. 2697

    One-Year Follow-Up of the Effectiveness of Cognitive Behavioral Group Therapy for Patients’ Depression: A Randomized, Single-Blinded, Controlled Study by Kai-Jo Chiang, Tsai-Hui Chen, Hsiu-Tsu Hsieh, Jui-Chen Tsai, Keng-Liang Ou, Kuei-Ru Chou

    Published 2015-01-01
    “…The aim of the study was to investigate the long-term (one year) effectiveness of a 12-session weekly cognitive behavior group therapy (CBGT) on patients with depression. This was a single-blind randomized controlled study with a 2-arm parallel group design. …”
    Get full text
    Article
  18. 2698
  19. 2699
  20. 2700

    Transition from Intravenous Epoprostenol to Oral or Subcutaneous Therapy in Pulmonary Arterial Hypertension: A Retrospective Case Series and Systematic Literature Review by Kirily Park, David Ostrow, Robert D Levy, John Swiston

    Published 2011-01-01
    “…BACKGROUND: Intravenous epoprostenol, a prostaglandin analogue, has been a mainstay of therapy for patients with advanced pulmonary arterial hypertension (PAH) since the early 1990s. …”
    Get full text
    Article